Healthcare & Life Sciences Transactions
News & Insights for Public Companies
- Kirkland Advises Eli Lilly on Acquisition of Verve Therapeutics for up to $1.3 Billion
- Kirkland Advises Sage Therapeutics on Sale to Supernus Pharmaceuticals for up to $795 Million
- Kirkland Advises Blackstone on Majority Investment in Chartis to Advance Mission of Healthcare Transformation
- Kirkland Advises Carlyle on $3.8 Billion Acquisition of Baxter’s Kidney Care Segment
- Kirkland Advises R1 RCM on $8.9 Billion Acquisition by TowerBrook and CD&R
- Kirkland Advises Owens & Minor on $1.36 Billion Acquisition of Rotech
- Kirkland Advises Eli Lilly on $3.2 Billion Morphic Acquisition
- Kirkland Advises Phibro Animal Health on Acquisition of Assets from Zoetis
- Kirkland Represents GL Capital on Proposed Privatization of SciClone Pharmaceuticals